Search results for "failure"

showing 10 items of 1977 documents

Long-Term Enoximone Therapy in Unstable Chronic Heart Failure

1989

Long-term safety and efficacy of oral enoximone were evaluated in 32 patients with unstable chronic heart failure despite digitalis, diuretics, and vasodilator therapy. Oral enoximone, 75-150 mg t.i.d. was given for an average of 32 weeks. At baseline, 21 patients were in NYHA functional class IV, 10 patients in class III, and 1 patient in class II. Within 12 weeks, 14 of 20 patients surviving for more than 26 weeks had improved by at least one functional class. Hemodynamic data showed an 18% increase of cardiac index and a 34% decrease of diastolic pulmonary artery pressure. Echocardiographic recordings revealed an increase of fractional shortening from 13.9 +/- 7 to 15.6 +/- 5% after 12 w…

AdultMalemedicine.medical_specialtyCardiotonic AgentsHeart diseaseCardiac indexDiastoleSudden deathElectrocardiographyInternal medicinemedicine.arterymedicineHumansEnoximoneEnoximoneSurvival rateAgedAged 80 and overHeart FailurePharmacologybusiness.industryHemodynamicsImidazolesMiddle Agedmedicine.diseaseSurgeryHeart failureChronic DiseasePulmonary arteryCardiologyFemalebusinessCardiology and Cardiovascular Medicinemedicine.drugJournal of Cardiovascular Pharmacology
researchProduct

Refined atrial fibrillation screening and cost-effectiveness in the German population

2021

ObjectiveLittle is known on optimal screening population for detecting new atrial fibrillation (AF) in the community. We describe characteristics and estimate cost-effectiveness for a single timepoint electrocardiographic screening.MethodsWe performed a 12-lead ECG in the German population-based Gutenberg Health Study between 2007 and 2012 (n=15 010), mean age 55±11 years, 51% men and collected more than 120 clinical and biomarker variables, including N-terminal pro B-type natriuretic peptide (Nt-proBNP), risk factors, disease symptoms and echocardiographic variables.ResultsOf 15 010 individuals, 466 (3.1%) had AF. New AF was found in 32 individuals, 0.2% of the total sample, 0.5% of indivi…

AdultMalemedicine.medical_specialtyCost effectivenessCost-Benefit AnalysisPopulation030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicineInternal medicineAtrial FibrillationNatriuretic Peptide BrainEpidemiologyHumansMedicine030212 general & internal medicineRisk factoreducationStrokeAgedHeart Failureeducation.field_of_studybusiness.industryAtrial fibrillationMiddle Agedmedicine.diseasePeptide Fragments3. Good healthStrokeHeart failureBiomarker (medicine)FemaleCardiology and Cardiovascular MedicinebusinessBiomarkersHeart
researchProduct

The distribution of whole blood viscosity, its determinants and relationship with arterial blood pressure in the community: cross-sectional analysis …

2015

Background: Blood viscosity has a role in modulating cardiovascular homeostasis; changes in this parameter have been associated with cardiovascular mortality and morbidity. However, it remains unclear whether these changes are (1) involved in the pathophysiology of disease, (2) an epiphenomenon, or (3) the expression of counterregulatory mechanisms. We report data on the normal values of blood viscosity and its association with cardiovascular risk factors, prevalent cardiovascular disease, and blood pressure in a large population-based cohort study. Methods and results: Viscosity was calculated using validated formulae and its associations were explored in 15,010 participants (mean 55.0, mi…

AdultMalemedicine.medical_specialtyCross-sectional studyBlood viscosityDiseaseCoronary Artery DiseaseRisk AssessmentReference ValuesRisk FactorsInternal medicineGermanymedicinePrevalenceHumansPharmacology (medical)Arterial PressureAgedHeart Failurebusiness.industryWhole blood viscosityRegression analysisMiddle AgedBlood ViscosityHealth SurveysPathophysiologySurgeryBlood pressureCross-Sectional StudiesLogistic ModelsCardiovascular DiseasesCohortCardiologyLinear ModelsFemaleCardiology and Cardiovascular MedicinebusinessTherapeutic advances in cardiovascular disease
researchProduct

The joint impact of donor and recipient parameters on the outcome of heart transplantation in Germany after graft allocation.

2013

Organ shortage in heart transplantation (HTx) results in increased use of grafts from donors with substantial risk factors. It is discussed controversially which donor characteristics may be detrimental. Therefore, we evaluated the joint impact of donor- and patient-related risk factors in HTx on patient survival by multiple analysis in a nationwide multicentre study after donor selection was carried out. The research database consists of data concerning hearts donated and transplanted in Germany between 2006 and 2008 as provided by Deutsche Stiftung Organtransplantation and the BQS Institute. Multiple Cox regression (significance level 5%, hazard ratio [95% CI]) was conducted (n = 774, rec…

AdultMalemedicine.medical_specialtyDatabases Factualmedicine.medical_treatmentDonor SelectionYoung AdultRisk FactorsInternal medicineGermanymedicineHumansCause of deathProportional Hazards ModelsHeart transplantationHeart FailureTransplantationbiologyProportional hazards modelDonor selectionbusiness.industryHazard ratioGraft SurvivalAge FactorsMiddle Agedmedicine.diseasePulmonary hypertensionTroponinSurvival AnalysisTissue DonorsSurgerymedicine.anatomical_structureTreatment OutcomeMultivariate AnalysisCardiologyVascular resistancebiology.proteinHeart TransplantationFemalebusinessTransplant international : official journal of the European Society for Organ Transplantation
researchProduct

Digoxin concentrations in serum and cantharides blister fluid: correlations with cardiac response.

1987

The relationship between the pharmacokinetics and dynamics of digoxin was investigated using a skin blistering technique that allows experimental access to tissue fluid concentrations. Eight healthy volunteers received digoxin, 1.0 mg, and placebo intravenously according to a double-blind crossover design. Drug concentrations were determined during a 72-hour period in serum, urine, and cantharides blister fluid (CBF). Digoxin levels in the hypothetic peripheral compartments were calculated from serum concentrations. Digoxin effects (total electromechanical systole [QS2c], left ventricular ejection time [LVETc], preejection period [PEPc], QTc time, heart rate, and T wave amplitude) were meas…

AdultMalemedicine.medical_specialtyDigoxinDigoxinSystoleUrineQT intervalElectrocardiographyBlisterPharmacokineticsInternal medicineHeart ratemedicineHumansPharmacology (medical)PharmacologyChemistryHeartmedicine.diseaseCrossover studySuction blisterEndocrinologyHeart failureCardiologyFemalecirculatory and respiratory physiologymedicine.drugClinical pharmacology and therapeutics
researchProduct

Clinical course and outcomes of drug-induced liver injury: Nimesulide as the first implicated medication

2010

Abstract Background and aims Drug-induced liver injury (DILI) is the most common cause of death from acute liver failure, and accounts for approximately 13% of cases of acute liver failure in the United States. The clinical presentation of DILI covers a wide spectrum, from asymptomatic liver test abnormalities to symptomatic acute liver disease, prolonged jaundice and disability, or overt acute or subacute liver failure. The aim of our study was to evaluate the number of DILI cases admitted to our Unit and to identify the drugs responsible. Thus, we reviewed all clinical records of patients with DILI admitted to our Unit from 1996 to 2006. Patients and methods A database was constructed, re…

AdultMalemedicine.medical_specialtyEncephalopathySex FactorsAnti-Infective AgentsInternal medicineAscitesmedicineHumansAgedRetrospective StudiesNimesulideLiver injuryPsychotropic DrugsSulfonamidesHepatologymedicine.diagnostic_testbusiness.industryAnti-Inflammatory Agents Non-SteroidalHepatotoxicityAge FactorsGastroenterologyMiddle AgedJaundicemedicine.diseaseSurgeryDiscontinuationHepatotoxicity; Liver function tests; NimesulideLiver function testFemaleChemical and Drug Induced Liver Injurymedicine.symptombusinessLiver function testsLiver FailureAdverse drug reactionNimesulidemedicine.drugDigestive and Liver Disease
researchProduct

Non-fatal and fatal liver failure associated with valproic acid.

2012

Little is known about hepatotoxicity associated with valproic acid (VPA), a widely used substance in neuropsychiatry.All reported cases to the German Federal Institute for Drugs and Medical Devices between 1993 and 2009 of VPA-induced serious hepatic side effects were evaluated.A total of 132 cases of serious VPA-associated liver failure were identified. Approximately one third (34.8%) occurred under VPA monotherapy, while the majority was seen with VPA plus co-medication, most frequently antiepileptics (34.8%) and benzodiazepines (16.7%). A subgroup of 34 cases (25.8%) had a fatal outcome, the largest number reported to date. Of these, 32.4% were under VPA monotherapy and 67.6% under VPA p…

AdultMalemedicine.medical_specialtyFatal outcomeAdolescentGastroenterologyBenzodiazepinesPharmacovigilancePharmacotherapyInternal medicineGermanyPharmacovigilancemedicineHumansPharmacology (medical)ChildAgedAged 80 and overValproic Acidbusiness.industryValproic AcidLiver failureInfantGeneral MedicineMiddle AgedPsychiatry and Mental healthAnesthesiaConcomitantChild Preschoollipids (amino acids peptides and proteins)AnticonvulsantsDrug Therapy CombinationFemaleChemical and Drug Induced Liver Injurybusinessmedicine.drugPharmacopsychiatry
researchProduct

Oxidative stress markers in the neocortex of drug-resistant epilepsy patients submitted to epilepsy surgery

2013

Summary Purpose While there is solid experimental evidence of brain oxidative stress in animal models of epilepsy, it has not been thoroughly verified in epileptic human brain. Our purpose was to determine and to compare oxidative stress markers in the neocortex of epileptic and non-epileptic humans, with the final objective of confirming oxidative stress phenomena in human epileptic brain. Methods Neocortical samples from drug-resistant epilepsy patients submitted to epilepsy surgery ( n =20) and from control, non-epileptic cortex samples ( n =11) obtained from brain bank donors without neurological disease, were studied for oxidative stress markers: levels of reactive oxygen species (ROS)…

AdultMalemedicine.medical_specialtyGlutathione reductaseNeocortexBiologymedicine.disease_causeLipid peroxidationSuperoxide dismutasechemistry.chemical_compoundEpilepsyInternal medicinemedicineHumansTreatment Failurechemistry.chemical_classificationGlutathione PeroxidaseReactive oxygen speciesEpilepsySuperoxide DismutaseGlutathione peroxidaseMiddle AgedCatalasemedicine.diseasePsychosurgeryOxidative StressGlutathione ReductaseEndocrinologyNeurologyBiochemistrychemistryCatalaseRetreatmentbiology.proteinAnticonvulsantsFemaleNeurology (clinical)BiomarkersOxidative stressEpilepsy Research
researchProduct

Biomarkers for characterization of heart failure - Distinction of heart failure with preserved and reduced ejection fraction.

2016

Heart failure (HF) incidence is rising worldwide and HF with preserved ejection fraction (HFpEF) represents nearly half of all cases. Treatment options are still limited in HFpEF in comparison to HF with reduced ejection fraction (HFrEF).We analyzed biomarkers in the general population to characterize HFpEF and HFrEF and defined a biomarker index to differentiate HFpEF from HFrEF. Growth differentiation factor-15 (GDF-15), soluble source of tumorigenicity 2 (sST2), C-reactive protein (CRP) and NT-proBNP were measured in 5000 individuals of the population-based Gutenberg Health Study (GHS). The median follow-up time for all-cause mortality was 7.3years with 213 events.Identification of subje…

AdultMalemedicine.medical_specialtyGrowth Differentiation Factor 15Population030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicinePredictive Value of TestsInternal medicineNatriuretic Peptide BrainmedicineHumans030212 general & internal medicineeducationAgedHeart Failureeducation.field_of_studyEjection fractionbiologybusiness.industryIncidence (epidemiology)C-reactive proteinTreatment optionsStroke VolumeMiddle Agedmedicine.diseasePrognosisInterleukin-1 Receptor-Like 1 ProteinPeptide FragmentsC-Reactive ProteinHeart failurebiology.proteinCardiologyBiomarker (medicine)FemaleGDF15Cardiology and Cardiovascular MedicinebusinessBiomarkersInternational journal of cardiology
researchProduct

Sociocognitive factors associated with nonadherence to medication after hospital discharge

2010

Poor adherence to prescribed medication is a well-known problem and continues to be a major challenge in all medical specialties. Unlike previous studies that have mainly focused on nonadherence behaviors in specific diseases, this study sought to examine socio-cognitive factors associated with nonadherence behavior in a sample of a general clinical population. A questionnaire investigating socio-demographic and cognitive factors and a telephone follow-up interview were administered to 84 patients recruited in a General Medicine Unit before their discharge. Half of the participants were informed about that follow-up procedure. One month after hospital discharge, 42% of uninformed patients r…

AdultMalemedicine.medical_specialtyHealth Knowledge Attitudes PracticePopulationcognitive failuresMedication AdherencePoor adherencepostdischarge patientrisk perceptionSurveys and QuestionnairesHospital dischargeHumansMedicineSurveys and QuestionnaireAge FactorRisks and benefitseducationPsychiatryApplied PsychologyAgedadherence monitoringAged 80 and overeducation.field_of_studycognitive failureSettore M-PSI/02 - Psicobiologia E Psicologia Fisiologicabusiness.industryadherence monitoring; cognitive failures; postdischarge patients; risk perceptionAge FactorsCognitionMiddle AgedPatient DischargeRisk perceptionPsychiatry and Mental HealthAdherence monitoringFemalebusinesspostdischarge patientsHuman
researchProduct